Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Income Statement [Abstract]        
Sales $ 2,086,986 $ 4,734,148 $ 5,764,116 $ 12,860,988
Cost of sales (977,165) (2,827,922) (3,742,495) (7,703,507)
Gross profit 1,109,821 1,906,226 2,021,621 5,157,481
Operating Expenses:        
General and adminstrative expenses 1,373,459 1,352,748 3,884,886 4,236,747
Selling expenses 86,772 59,029 386,986 407,284
Research and development expenses 55,390 155,941 81,066 584,059
Total Operating Expenses 1,515,621 1,567,718 4,352,938 5,228,090
Income (Loss) from operations (405,800) 338,508 (2,331,317) (70,609)
Interest expense (991,601) (482,960) (1,948,686) (4,970,657)
Change in fair market value of derivative liability (4,660,841) 21,912 (4,148,748) 477,830
Loss before income taxes (6,058,242) (122,540) (8,428,751) (4,563,436)
Income taxes            
Net loss from continuing operations (6,058,242) (122,540) (8,428,751) (4,563,436)
Income from discontinued operations, net of taxes 64,058 23,810 212,848 104,232
Gain on sale of assets 685,653    685,653  
Net loss $ (5,308,531) $ (98,730) $ (7,530,250) $ (4,459,204)
Net loss per common share from continuing operations $ (0.09) $ 0.00 $ (0.13) $ (0.07)
Net income per common share from discontinued operations $ 0.01 $ 0.00 $ 0.01 $ 0.00
Net loss per common share $ (0.08) $ 0.00 $ (0.12) $ (0.07)
Basic and diluted weighted average common shares outstanding 70,098,825 69,418,903 67,119,343 61,631,047